• About us
  • Our scope
  • Our team
  • Our supporters
  • Contacting us
  • Our newsletter
  • Reports
  • Brochures
  • Renal conferences
  • Related web sites
• Reviews
  • Renal reviews
  • Renal protocols
  • Renal titles
• Writing a review
  • Potential review titles
  • Review process
    • Overview
    • Developing a title
    • Developing a protocol
    • Developing a review
    • Updating a review
  • For authors
  • For referees
  • Becoming involved
  • Workshops
• Trials in nephrology
  • Ongoing trials
• Diagnostic reviews
  • Diagnostic review titles
• Prospective trial registration
  • Search for a registered study
• What's new?
• Home

Cochrane Renal Protocols

The following renal protocols are 'works in progress' and are published in the Cochrane Library. A subscription may be required if you are accessing the full-text of the Cochrane Library from outside Australia.

• Advanced glycation end product (AGE) inhibitors for preventing the progression of diabetic kidney disease
• Alpha-blockers as medical expulsive therapy for ureteral stones
• Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
• Androgens for the anaemia of chronic kidney disease in adults
• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non diabetic chronic kidney disease
• Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
• Antibiotics for preventing urinary tract infections in kidney transplant recipients/
• Antibiotics for treating uncomplicated urinary tract infection in children
• Antibody immunosuppression for pancreas and kidney pancreas transplant recipients
• Antihypertensive agents for dialysis patients
• Antihypertensive agents for preventing the progression of diabetic kidney disease
• Antioxidants for chronic kidney disease
• Antiplatelet agents for chronic kidney disease

• Bicarbonate versus lactate solutions for acute haemodialysis
• Biocompatible dialysis fluids for peritoneal dialysis

• Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
• Calcium dialysate concentration for peritoneal dialysis
• Cardiac testing for coronary artery disease in potential kidney transplant recipients
DIAGNOSTIC REVIEW
• Chinese medicinal herbs for diabetic kidney disease
• Chinese medicinal herbs for urinary calculi
• Continuous renal replacement therapy (CRRT) for rhabdomyolysis
• Cordyceps sinensis (a Chinese medicinal herb) for treating chronic kidney diseasey

• Dietary interventions for preventing complications in idiopathic hypercalciuria
• Diuretics for treating oedema in nephrotic syndrome
• Donor organs preservation techniques for kidney transplantation

• Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
• Education programmes for people with diabetic kidney disease
• Endoscopic treatment with or without stenting for the management of ureteric calculi
• Exercise training for chronic kidney disease patients

• FTY720 immunosuppression for kidney transplant recipients

• Growth factors for chronic kidney disease in adults

• Heparin and related substances for delaying the progression of diabetic kidney disease
• High-flux versus low-flux haemodialysis membranes for end-stage renal disease
• HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass

• Insulin-sensitising therapies for preventing the progression of diabetic kidney disease
• Intensive versus standard haemodialysis water treatment for preventing low grade mineral intoxication in chronic haemodialysed patients
• Interventions for covert bacteriuria in children
• Interventions for dialysis patients with hepatitis C virus (HCV) infection
• Interventions for erythropoietin-resistant anaemia in dialysis patients
• Interventions for lowering plasma homocysteine levels in predialysis patients
• Interventions for lowering plasma homocysteine levels in dialysis patients
• Interventions for lowering plasma homocysteine levels in kidney transplant recipients
• Interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
• Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units

• Laparoscopic versus open nephrectomy for live kidney donors
• Lipid-lowering agents for nephrotic syndrome
• Low molecular weight heparin (LMWH) versus unfractionated heparin (UFH) for haemodialysis anticoagulation

• Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

• Non-steroidal anti-inflammatory drugs (NSAIDS) and non-opioids for acute renal colic

• Oral absorbents for preventing or delaying the progression of chronic kidney disease
• Parenteral versus oral iron therapy for adults and children with chronic kidney disease
• Pentoxifylline for diabetic kidney disease
• Percussion, diuresis and inversion therapy for the passage of lower pole kidney stones after shock wave lithotripsy
• Pharmacological interventions for preventing contrast-induced nephropathy
• Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
• Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients/
• Preoperative vascular access evaluation for haemodialysis patients
• Probiotics for preventing urinary tract infections in adults and children

• Radix Astragali (a Chinese medicinal herb) for treating chronic kidney disease
• Recombinant human insulin-like growth factor I for acute kidney injury
• Renal replacement therapy for preventing contrast-induced nephropathy
• Rheum officinale (a Chinese medicinal herb) for chronic kidney disease

• Single dose antibiotics for treating uncomplicated urinary tract infection in non-pregnant women
• Sodium ferulate for preventing the progression of diabetic kidney disease
• Steroid avoidance or withdrawal for pancreas and kidney transplant recipients

• Tacrolimus for simultaneous kidney-pancreas transplant recipients
• Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
• Therapeutic interventions for membranoproliferative glomerulonephritis
• Thyroxine for acute kidney injury
• Tidal peritoneal dialysis for acute renal failure
• Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome

• Ultrasound use for the placement of haemodialysis catheters
• Upper limb exercise for haemodialysis fistula surgery

Introduction to writing
a Cochrane systematic review:
Sydney workshops 2012
[Details]

Are you interested in writing a review?

Contact us for potential review titles!

Help us with our Renal Trials Register

Do you have conference proceedings [books or cd-roms] that you no longer need or could lend to us for hadsearching? If so, email Ruth Mitchell for details

Handsearching

Are you interested in helping us handsearch journals or conference proceedings. To find out more about our handsearching activities, email Ruth Mitchell